Security Snapshot

Twist Bioscience Corp - COMMON STOCK (TWST) Institutional Ownership

CUSIP: 90184D100

13F Institutional Holders and Ownership History from Q4 2018 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

330

Shares (Excl. Options)

76,225,244

Price

$102.88

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
-610,704
Value change
+$56,997,914
Number of holders
330
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
62,663,276
SEC-reported price per share
$92.44
Insider filing price
$92.44
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • TWST - Twist Bioscience Corp - COMMON STOCK is tracked under CUSIP 90184D100.
  • 330 institutions reported positions in Q2 2026.
  • 10 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 279 to 330 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $3,657,661,884 to $7,840,579,764.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 330 institutions filings for Q2 2026.

Open SEC evidence

Security key

90184D100

Latest holder period

Q2 2026

13F holders

330

13D/G owners

10

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
10
Security
TWST
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.3% $197,947,718 4,927,750 BlackRock, Inc. 31 Mar 2025
Artisan Partners Limited Partnership 7.7% -24% $433,862,236 -$127,862,959 4,802,017 -23% Artisan Partners Asset Management Inc. 30 Jun 2026
FMR LLC 7.6% $424,920,035 4,703,044 FMR LLC 30 Jun 2026
ARK Investment Management LLC 7.3% -30% $411,074,701 -$161,991,226 4,549,803 -28% ARK Investment Management LLC 30 Jun 2026
PRICE T ROWE ASSOCIATES INC /MD/ 5.8% $328,374,364 3,634,470 T. Rowe Price Associates, Inc. 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC 5% $147,402,716 3,101,909 Vanguard Capital Management 31 Mar 2026
STATE STREET CORP 5.1% +20% $86,926,233 +$15,338,157 3,089,063 +21% STATE STREET CORPORATION 30 Sep 2025
EdgePoint Investment Group Inc. 4.2% -51% $227,829,722 -$258,071,765 2,521,635 -53% EdgePoint Investment Group Inc. 30 Jun 2026
Invesco Ltd. 3.9% $91,850,982 2,347,929 Invesco Ltd. 30 Jun 2025
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 3.5% -57% $196,474,568 -$279,644,453 2,174,594 -59% WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 30 Jun 2026

As of 30 Jun 2026, 330 institutional investors reported holding 76,225,244 shares of Twist Bioscience Corp - COMMON STOCK (TWST). This represents 122% of the company’s total 62,663,276 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
88%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 9.3% 5,833,891 +5% 0.01% $600,190,704
Artisan Partners Limited Partnership 7.7% 4,802,017 -25% 0.81% $494,031,558
FMR LLC 7.5% 4,703,044 +149% 0.02% $483,849,178
ARK Investment Management LLC 7.3% 4,549,803 -28% 3% $468,083,756
PRICE T ROWE ASSOCIATES INC /MD/ 5.8% 3,634,652 +5070% 0.04% $373,934,000
STATE STREET CORP 5.2% 3,232,532 -12% 0.01% $332,562,892
VANGUARD PORTFOLIO MANAGEMENT LLC 4.5% 2,824,989 +6.6% 0.01% $290,634,868
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 2,699,280 +2.3% 0.01% $277,701,926
EdgePoint Investment Group Inc. 4% 2,521,635 -53% 2% $259,425,809
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 3.5% 2,174,594 -59% 0.67% $223,722,231
FARALLON CAPITAL MANAGEMENT, L.L.C. 3.4% 2,136,400 +50% 1.3% $219,792,832
Invesco Ltd. 3.1% 1,928,229 -11% 0.02% $198,376,199
GEODE CAPITAL MANAGEMENT, LLC 2.6% 1,619,361 +6.6% 0.01% $166,632,638
Thrivent Financial for Lutherans 2.3% 1,433,503 +9.2% 0.25% $147,479,000
GOLDMAN SACHS GROUP INC 2.2% 1,408,418 -17% 0.02% $144,898,045
MORGAN STANLEY 1.9% 1,189,861 +118% 0.01% $122,412,922
D. E. Shaw & Co., Inc. 1.9% 1,185,605 +2442% 0.08% $121,975,042
BAILLIE GIFFORD & CO 1.7% 1,086,779 -11% 0.1% $111,807,823
Driehaus Capital Management LLC 1.6% 1,022,526 +75% 0.61% $105,197,475
Sumitomo Mitsui Trust Group, Inc. 1.6% 1,000,344 -33% 0.06% $102,915,391
Amova Asset Management Americas, Inc. 1.6% 999,734 -33% 1.3% $102,842,637
BANK OF AMERICA CORP /DE/ 1.5% 922,647 +58% 0.01% $94,921,922
CITADEL ADVISORS LLC 1.4% 862,042 -29% 0.05% $88,686,881
LOOMIS SAYLES & CO L P 1.4% 861,309 +75% 0.11% $88,611,470
Stephens Investment Management Group LLC 1.2% 767,364 0.85% $78,946,408

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
31
Latest
Q2 2026
Rows shown
1-25 of 31
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 76,225,244 $7,840,579,764 +$56,997,914 $102.88 330
2026 Q1 77,009,445 $3,657,661,884 +$106,110,180 $47.52 279
2025 Q4 75,001,500 $2,379,251,318 +$34,609,404 $31.72 242
2025 Q3 73,764,582 $2,075,556,896 +$57,804,960 $28.14 235
2025 Q2 71,133,390 $2,616,814,853 +$58,445,660 $36.79 240
2025 Q1 69,532,083 $2,729,868,536 +$98,718,253 $39.26 260
2024 Q4 66,360,913 $3,083,489,168 +$6,148,856 $46.47 244
2024 Q3 66,073,350 $2,986,931,967 -$9,670,153 $45.18 240
2024 Q2 65,972,475 $3,251,056,592 +$28,344,193 $49.28 256
2024 Q1 67,075,830 $2,301,195,873 +$12,173,886 $34.31 230
2023 Q4 66,744,591 $2,459,763,309 +$20,095,641 $36.86 215
2023 Q3 66,341,769 $1,344,049,066 -$31,879,539 $20.26 191
2023 Q2 68,103,043 $1,393,371,812 +$106,475,508 $20.46 185
2023 Q1 63,810,827 $961,273,962 +$17,347,246 $15.08 197
2022 Q4 62,336,899 $1,484,114,188 +$31,639,333 $23.81 191
2022 Q3 59,850,512 $2,097,211,101 +$44,899,500 $35.24 206
2022 Q2 57,994,411 $2,008,438,723 -$90,076,201 $34.96 188
2022 Q1 54,121,106 $2,662,382,357 +$281,218,717 $49.38 193
2021 Q4 51,230,952 $3,958,124,330 +$152,934,374 $77.39 224
2021 Q3 48,658,857 $5,195,018,312 +$41,898,607 $106.97 229
2021 Q2 48,123,755 $6,401,051,212 +$152,118,907 $133.25 240
2021 Q1 46,988,226 $5,820,040,994 +$482,887,437 $123.86 234
2020 Q4 42,909,917 $6,062,828,297 +$547,775,260 $141.29 215
2020 Q3 39,702,868 $3,018,023,941 +$217,077,489 $75.97 191
2020 Q2 37,011,859 $1,675,114,837 +$285,296,567 $45.30 141
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .